Targeted DNA sequencing of high-grade serous ovarian carcinoma reveals association of TP53 mutations with platinum resistance when combined with gene expression.
Saved in:
| Title: | Targeted DNA sequencing of high-grade serous ovarian carcinoma reveals association of TP53 mutations with platinum resistance when combined with gene expression. |
|---|---|
| Authors: | Holý P; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Hlaváč V; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Šeborová K; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Šůsová S; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Tesařová T; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Rob L; Department of Gynecology and Obstetrics, Third Faculty of Medicine and University Hospital Kralovske Vinohrady, Prague, Czech Republic., Hruda M; Department of Gynecology and Obstetrics, Third Faculty of Medicine and University Hospital Kralovske Vinohrady, Prague, Czech Republic., Bouda J; Department of Gynecology and Obstetrics, University Hospital in Pilsen, Charles University, Pilsen, Czech Republic., Bartáková A; Department of Gynecology and Obstetrics, University Hospital in Pilsen, Charles University, Pilsen, Czech Republic., Mrhalová M; Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University, Prague, Czech Republic., Kopečková K; Department of Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic., Al Obeed Allah M; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Špaček J; University Hospital Hradec Králové, Hradec Kralove, Czech Republic., Sedláková I; University Hospital Hradec Králové, Hradec Kralove, Czech Republic., Souček P; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic., Václavíková R; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. |
| Source: | International journal of cancer [Int J Cancer] 2024 Jul 01; Vol. 155 (1), pp. 104-116. Date of Electronic Publication: 2024 Mar 06. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38447012 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Targeted DNA sequencing of high-grade serous ovarian carcinoma reveals association of TP53 mutations with platinum resistance when combined with gene expression. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Holý+P%22">Holý P</searchLink>; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Hlaváč+V%22">Hlaváč V</searchLink>; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Šeborová+K%22">Šeborová K</searchLink>; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Šůsová+S%22">Šůsová S</searchLink>; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Tesařová+T%22">Tesařová T</searchLink>; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Rob+L%22">Rob L</searchLink>; Department of Gynecology and Obstetrics, Third Faculty of Medicine and University Hospital Kralovske Vinohrady, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Hruda+M%22">Hruda M</searchLink>; Department of Gynecology and Obstetrics, Third Faculty of Medicine and University Hospital Kralovske Vinohrady, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Bouda+J%22">Bouda J</searchLink>; Department of Gynecology and Obstetrics, University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Bartáková+A%22">Bartáková A</searchLink>; Department of Gynecology and Obstetrics, University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Mrhalová+M%22">Mrhalová M</searchLink>; Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Kopečková+K%22">Kopečková K</searchLink>; Department of Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Al+Obeed+Allah+M%22">Al Obeed Allah M</searchLink>; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Špaček+J%22">Špaček J</searchLink>; University Hospital Hradec Králové, Hradec Kralove, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Sedláková+I%22">Sedláková I</searchLink>; University Hospital Hradec Králové, Hradec Kralove, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Souček+P%22">Souček P</searchLink>; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Václavíková+R%22">Václavíková R</searchLink>; Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220042124%22">International journal of cancer</searchLink> [Int J Cancer] 2024 Jul 01; Vol. 155 (1), pp. 104-116. <i>Date of Electronic Publication: </i>2024 Mar 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Liss%22">Wiley-Liss </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0042124 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0215 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200207136%22">00207136 </searchLink><i>NLM ISO Abbreviation: </i>Int J Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38447012 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/ijc.34908 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 104 Titles: – TitleFull: Targeted DNA sequencing of high-grade serous ovarian carcinoma reveals association of TP53 mutations with platinum resistance when combined with gene expression. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Holý P – PersonEntity: Name: NameFull: Hlaváč V – PersonEntity: Name: NameFull: Šeborová K – PersonEntity: Name: NameFull: Šůsová S – PersonEntity: Name: NameFull: Tesařová T – PersonEntity: Name: NameFull: Rob L – PersonEntity: Name: NameFull: Hruda M – PersonEntity: Name: NameFull: Bouda J – PersonEntity: Name: NameFull: Bartáková A – PersonEntity: Name: NameFull: Mrhalová M – PersonEntity: Name: NameFull: Kopečková K – PersonEntity: Name: NameFull: Al Obeed Allah M – PersonEntity: Name: NameFull: Špaček J – PersonEntity: Name: NameFull: Sedláková I – PersonEntity: Name: NameFull: Souček P – PersonEntity: Name: NameFull: Václavíková R IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2024 Jul 01 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1097-0215 Numbering: – Type: volume Value: 155 – Type: issue Value: 1 Titles: – TitleFull: International journal of cancer Type: main |
| ResultId | 1 |
